Merck matches Roche in search for next cancer immunotherapy
Bio Pharma Dive
SEPTEMBER 21, 2020
The maker of Keytruda unveiled data for three experimental cancer drugs, including results for an anti-TIGIT therapy that compare favorably to those for a similar medicine being developed by Roche.
Let's personalize your content